Lorbrena and Nosebleed - a phase IV clinical study of FDA data


Nosebleed is reported only by a few people who take Lorbrena.

The phase IV clinical study analyzes which people take Lorbrena and have Nosebleed. It is created by eHealthMe based on reports of 1,278 people who have side effects while taking Lorbrena from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

1,278 people reported to have side effects when taking Lorbrena.
Among them, 2 people (0.16%) have Nosebleed.

What is Lorbrena?

Lorbrena has active ingredients of lorlatinib. eHealthMe is studying from 1,278 Lorbrena users for its effectiveness, alternative drugs and more.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 3,246 drugs and 2,840 conditions by eHealthMe.

Number of Lorbrena and Nosebleed reports submitted per year:

Could Lorbrena cause Nosebleed?

Time on Lorbrena when people have Nosebleed *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Nosebleed when taking Lorbrena *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Nosebleed when taking Lorbrena *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Lorbrena *:

  1. Cyramza: 1 person, 50.00%

Common side effects people have besides Nosebleed *:

  1. Weakness: 2 people, 100.00%
  2. Influenza Like Illness: 1 person, 50.00%
  3. Breathing Difficulty: 1 person, 50.00%
  4. Cerebral Haemorrhage (bleeding within the brain): 1 person, 50.00%
  5. Chest Pain: 1 person, 50.00%
  6. Choking Sensation (feeling of obstruction in respiratory system): 1 person, 50.00%
  7. Communication Disorder (speech and language disorder): 1 person, 50.00%
  8. Cough: 1 person, 50.00%
  9. Diarrhea: 1 person, 50.00%
  10. Dizziness: 1 person, 50.00%

Common conditions people have *:

  1. Venous Thrombosis (blood clot (thrombus) that forms within a vein): 1 person, 50.00%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 50.00%
  3. Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 50.00%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 50.00%
  5. Cancer Pain: 1 person, 50.00%
  6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lorbrena and have Nosebleed?

Check whether Nosebleed is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Nosebleed and when was it recovered:

Expand to all the drugs that have ingredients of lorlatinib:

Alternative drugs to, pros and cons of Lorbrena:

Common Lorbrena side effects:

Browse all side effects of Lorbrena:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nosebleed treatments and more:

COVID vaccines that are related to Nosebleed:

Common drugs associated with Nosebleed:

All the drugs that are associated with Nosebleed:

Common conditions associated with Nosebleed:

All the conditions that are associated with Nosebleed:

How the study uses the data?

The study uses data from the FDA. It is based on lorlatinib (the active ingredients of Lorbrena) and Lorbrena (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: